Skip to Content
Merck
CN

SML3533

BAY-0361

≥95% (HPLC)

Synonym(s):

(S)-2-(3-Cyano-2-(2′-fluoro-3′-methylbiphenyl-4-yl)-1,7-naphthyridin-4-ylamino)butanoic acid, BAY 0361, BAY 091 inactive control, BAY 091 negative control, BAY-091 inactive control, BAY-091 negative control, BAY0361, BAY091 inactive control, BAY091 negative control

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C26H21FN4O2
Molecular Weight:
440.47
UNSPSC Code:
12352200
NACRES:
NA.77

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

DVIVLYHDLNAXAT-NRFANRHFSA-N

SMILES string

N#CC1=C(N=C2C=NC=CC2=C1N[C@@H](CC)C(O)=O)C3=CC=C(C=C3)C4=C(C(C)=CC=C4)F

assay

≥95% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Quality Level

100

Biochem/physiol Actions

BAY-0361 is the inactive enantiomer of and negative control for the potent and highly selective PIP4K2A inhibitor BAY-091.
Inactive enantiomer of and negative control for the potent and highly selective PIP4K2A inhibitor BAY-091.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000221337
0000221339
0000221337
0000221339

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Lars Wortmann et al.
Journal of medicinal chemistry, 64(21), 15883-15911 (2021-10-27)
PIP4K2A is an insufficiently studied type II lipid kinase that catalyzes the conversion of phosphatidylinositol-5-phosphate (PI5P) into phosphatidylinositol 4,5-bisphosphate (PI4,5P2). The involvement of PIP4K2A/B in cancer has been suggested, particularly in the context of p53 mutant/null tumors. PIP4K2A/B depletion has

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service